STRATA CRITICAL MEDICAL, INC. Business Acquisition, Pro Forma Net Income (Loss)
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Business Acquisition, Pro Forma Net Income (Loss) of -$9.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2026-06-30 was -$9.82M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-12-31 was -$8.59M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-09-30 was -$7.57M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for the quarter ending 2025-06-30 was -$361.00K.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for fiscal 2025 was -$16.00M.
- STRATA CRITICAL MEDICAL, INC. business acquisition, pro forma net income (loss) for fiscal 2024 was -$15.84M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.82M 10-Q · filed 2026-08-04 | -$6.18M 10-Q · filed 2026-08-04 | ||
| 2025-12-31 | -$8.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$16.15M derived: sum of 2 quarters · filed 2026-03-03 | -$16.51M derived: sum of 3 quarters · filed 2026-08-04 | -$16.00M 10-K · filed 2026-03-03 |
| 2025-09-30 | -$7.57M 10-Q · filed 2025-11-10 | -$7.93M derived: sum of 2 quarters · filed 2026-08-04 | -$7.42M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$361.00K 10-Q · filed 2026-08-04 | -$311.00K 10-Q · filed 2026-08-04 | ||
| 2024-12-31 | -$10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$14.77M derived: sum of 2 quarters · filed 2026-03-03 | -$15.84M 10-K · filed 2026-03-03 | |
| 2024-09-30 | -$4.41M 10-Q · filed 2025-11-10 | -$5.47M 10-Q · filed 2025-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |